A Study to Compare the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profile of HLX17 Vs. Keytruda® in the First-Line Treatment of Advanced Non-squamous Non-small Cell Lung Cancer
PHASE3
This is a multicentre, randomized, double-blind, parallel-controlled integr...
Efficacy, Safety, and Tolerability of Gebasaxturev (V937) Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011)
PHASE2
This is a Phase 2 study to assess the efficacy, safety, and tolerability of...
The Efficacy and Safety of Neoadjuvant Therapy With Iparomlimab and Tuvonralimab in Locally Advanced MSI-H/dMMR Colorectal Cancer: An Prospective, Single-Arm Study (Neo-IT)
PHASE2
Immunotherapy may bring revolutionary changes to the preoperative neoadjuva...
Status
Active Not Recruiting
Location
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine,
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
PHASE3
Researchers are looking for new ways to treat people with proficient mismat...
Status
Recruiting
Location
University of South Alabama, Mitchell Cancer Institute ( Site 6033)